144 related articles for article (PubMed ID: 29741779)
1. N1-methylnicotinamide (MNAM) as a guardian of cardiovascular system.
Nejabati HR; Mihanfar A; Pezeshkian M; Fattahi A; Latifi Z; Safaie N; Valiloo M; Jodati AR; Nouri M
J Cell Physiol; 2018 Oct; 233(10):6386-6394. PubMed ID: 29741779
[TBL] [Abstract][Full Text] [Related]
2. Nicotinamide N-methyltransferase ameliorates renal fibrosis by its metabolite 1-methylnicotinamide inhibiting the TGF-β1/Smad3 pathway.
Zhang W; Rong G; Gu J; Fan C; Guo T; Jiang T; Deng W; Xie J; Su Z; Yu Q; Mai J; Zheng R; Chen X; Tang X; Zhang J
FASEB J; 2022 Mar; 36(3):e22084. PubMed ID: 35107844
[TBL] [Abstract][Full Text] [Related]
3. Nicotinamide and its metabolite N1-Methylnicotinamide alleviate endocrine and metabolic abnormalities in adipose and ovarian tissues in rat model of Polycystic Ovary Syndrome.
Nejabati HR; Samadi N; Shahnazi V; Mihanfar A; Fattahi A; Latifi Z; Bahrami-Asl Z; Roshangar L; Nouri M
Chem Biol Interact; 2020 Jun; 324():109093. PubMed ID: 32298659
[TBL] [Abstract][Full Text] [Related]
4. Nicotinamide-N-methyltransferase regulates lipid metabolism via SAM and 1-methylnicotinamide in the AML12 hepatocyte cell line.
Yoda M; Mizuno R; Izumi Y; Takahashi M; Bamba T; Kawaoka S
J Biochem; 2023 Jun; 174(1):89-98. PubMed ID: 37014628
[TBL] [Abstract][Full Text] [Related]
5. Activation of the nicotinamide N-methyltransferase (NNMT)-1-methylnicotinamide (MNA) pathway in pulmonary hypertension.
Fedorowicz A; Mateuszuk Ł; Kopec G; Skórka T; Kutryb-Zając B; Zakrzewska A; Walczak M; Jakubowski A; Łomnicka M; Słomińska E; Chlopicki S
Respir Res; 2016 Aug; 17(1):108. PubMed ID: 27581040
[TBL] [Abstract][Full Text] [Related]
6. N1-Methylnicotinamide: The Mysterious Anti-aging Actor in Renal Transplantation.
Nejabati HR; Roshangar L
Curr Pharm Des; 2023; 29(10):723-731. PubMed ID: 37005540
[TBL] [Abstract][Full Text] [Related]
7. Serum N1-Methylnicotinamide is Associated With Coronary Artery Disease in Chinese Patients.
Liu M; Chu J; Gu Y; Shi H; Zhang R; Wang L; Chen J; Shen L; Yu P; Chen X; Ju W; Wang Z
J Am Heart Assoc; 2017 Feb; 6(2):. PubMed ID: 28174167
[TBL] [Abstract][Full Text] [Related]
8. N1-methylnicotinamide as a possible modulator of cardiovascular risk markers in polycystic ovary syndrome.
Nejabati HR; Samadi N; Roshangar L; Nouri M
Life Sci; 2019 Oct; 235():116843. PubMed ID: 31494172
[TBL] [Abstract][Full Text] [Related]
9. N1-Methylnicotinamide: An Anti-Ovarian Aging Hormetin?
Nejabati HR; Schmeisser K; Shahnazi V; Samimifar D; Faridvand Y; Bahrami-Asl Z; Fathi-Maroufi N; Nikanfar S; Nouri M
Ageing Res Rev; 2020 Sep; 62():101131. PubMed ID: 32711159
[TBL] [Abstract][Full Text] [Related]
10. N1-Methylnicotinamide: Is it Time to Consider it as a Dietary Supplement for Athletes?
Nejabati HR; Ghaffari-Novin M; Fathi-Maroufi N; Faridvand Y; Holmberg HC; Hansson O; Nikanfar S; Nouri M
Curr Pharm Des; 2022; 28(10):800-805. PubMed ID: 35152860
[TBL] [Abstract][Full Text] [Related]
11. N1-methylnicotinamide impairs gestational glucose tolerance in mice.
Wei X; Tan Y; Huang J; Dong X; Feng W; Liu T; Yang Z; Yang G; Luo X
J Mol Endocrinol; 2024 Feb; 72(2):. PubMed ID: 38029302
[TBL] [Abstract][Full Text] [Related]
12. Protective Effects of N
Miwa T
Front Cell Neurosci; 2021; 15():634868. PubMed ID: 33889076
[TBL] [Abstract][Full Text] [Related]
13. Lipid droplets formation in human endothelial cells in response to polyunsaturated fatty acids and 1-methyl-nicotinamide (MNA); confocal Raman imaging and fluorescence microscopy studies.
Majzner K; Chlopicki S; Baranska M
J Biophotonics; 2016 Apr; 9(4):396-405. PubMed ID: 25966299
[TBL] [Abstract][Full Text] [Related]
14. Interferon-gamma elevates nicotinamide N-methyltransferase activity and nicotinamide level in human glioma cells.
Yamada K; Miyazaki T; Hara N; Tsuchiya M
J Nutr Sci Vitaminol (Tokyo); 2010; 56(2):83-6. PubMed ID: 20495288
[TBL] [Abstract][Full Text] [Related]
15. Nitric oxide production and endothelium-dependent vasorelaxation ameliorated by N1-methylnicotinamide in human blood vessels.
Domagala TB; Szeffler A; Dobrucki LW; Dropinski J; Polanski S; Leszczynska-Wiloch M; Kotula-Horowitz K; Wojciechowski J; Wojnowski L; Szczeklik A; Kalinowski L
Hypertension; 2012 Apr; 59(4):825-32. PubMed ID: 22353616
[TBL] [Abstract][Full Text] [Related]
16. Nicotinamide N-methyltransferase regulates hepatic nutrient metabolism through Sirt1 protein stabilization.
Hong S; Moreno-Navarrete JM; Wei X; Kikukawa Y; Tzameli I; Prasad D; Lee Y; Asara JM; Fernandez-Real JM; Maratos-Flier E; Pissios P
Nat Med; 2015 Aug; 21(8):887-94. PubMed ID: 26168293
[TBL] [Abstract][Full Text] [Related]
17. N-methylnicotinamide failed to induce endothelial prostacyclin release in perfused rat hindquarters.
Mogielnicki A; Kramkowski K; Hermanowicz JM; Buczko W
Pharmacol Rep; 2008; 60(6):1025-9. PubMed ID: 19212000
[TBL] [Abstract][Full Text] [Related]
18. Metabolism of NAD and N1-methylnicotinamide in growing and growth-arrested cells.
Johnson GS
Eur J Biochem; 1980 Dec; 112(3):635-41. PubMed ID: 6450682
[TBL] [Abstract][Full Text] [Related]
19. 1-Methylnicotinamide (MNA), a primary metabolite of nicotinamide, exerts anti-thrombotic activity mediated by a cyclooxygenase-2/prostacyclin pathway.
Chlopicki S; Swies J; Mogielnicki A; Buczko W; Bartus M; Lomnicka M; Adamus J; Gebicki J
Br J Pharmacol; 2007 Sep; 152(2):230-9. PubMed ID: 17641676
[TBL] [Abstract][Full Text] [Related]
20. Remote solid cancers rewire hepatic nitrogen metabolism via host nicotinamide-N-methyltransferase.
Mizuno R; Hojo H; Takahashi M; Kashio S; Enya S; Nakao M; Konishi R; Yoda M; Harata A; Hamanishi J; Kawamoto H; Mandai M; Suzuki Y; Miura M; Bamba T; Izumi Y; Kawaoka S
Nat Commun; 2022 Jun; 13(1):3346. PubMed ID: 35705545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
